Home › NDC Lookup › RxCUI directory › RxCUI 199663

Zidovudine 300 MG Oral Tablet — RxCUI 199663

RxNorm drug concept · Semantic clinical drug
RxCUI 199663 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI199663
Official nameZidovudine 300 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asAZT 300 MG Oral Tablet
FDA products mapped3
Package NDCs mapped4
Reported Medicaid activity (SDUD)163 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Zidovudine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The injectable form of Retrovir is used when you can't take medicine by mouth — for example, during surgery, labor, or if you're too unwell to swallow. It's given directly into a v...
  • Why am I getting zidovudine as an injection instead of a pill?
  • Yes — this is one of the most important uses of Retrovir. In a well-designed clinical study, treating HIV-positive mothers with zidovudine during pregnancy and labor, and then trea...
  • Can zidovudine really lower the chances of passing HIV to my baby?
📖 Read our full Zidovudine Injection guide →

🕸️ Concept Web — How Zidovudine 300 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Zidovudine 300 MG Oral Tablet RxCUI 199663

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Zidovudine 11413
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Zidovudine Oral Tablet 374332
    • Zidovudine Oral Product 1163028
    • Zidovudine Pill 1163029
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Zidovudine 300 MG 316916

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Zidovudine 300 MG SCDC · 316916
  • Zidovudine Oral Tablet SCDF · 374332
  • Zidovudine Oral Product SCDG · 1163028
  • Zidovudine Pill SCDG · 1163029

📦 FDA Products & Package NDCs

3 products · 4 package NDCs
4 package NDCs map to RxCUI 199663 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
31722-0509-60 12 BOTTLE in 1 CASE (31722-509-60) / 60 TABLET in 1 BOTTLE Zidovudine Camber Pharmaceuticals, Inc. 2008-04-25
65862-0024-10 6 BLISTER PACK in 1 CARTON (65862-024-10) / 10 TABLET, FILM... Zidovudine Aurobindo Pharma Limited 2005-09-19
65862-0024-60 60 TABLET, FILM COATED in 1 BOTTLE (65862-024-60) Zidovudine Aurobindo Pharma Limited 2005-09-19
67046-1613-03 30 TABLET in 1 BLISTER PACK (67046-1613-3) Zidovudine Coupler LLC 2025-11-13
Observed labelers: Aurobindo Pharma Limited (2) · Camber Pharmaceuticals, Inc. (1) · Coupler LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.